FIELD: medicine.
SUBSTANCE: blood plasma is examined for the relation of interleukin-18 to tumour necrosis factor-alpha (IL-18/TNF-α) prior to and after antiviral therapy. If the IL-18/TNF-α value is less than 2 prior to the therapy and increased up to 2 and more after the therapy, formation of virological response is predicted.
EFFECT: method enables prediction of stable virological response for the purpose of the following management.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1b | 2012 |
|
RU2522500C1 |
METHOD FOR PREDICTING THE ABSENCE OF REGRESS OF HEPATIC FIBROSIS IN THE PATIENTS WITH CHRONIC HEPATITIS C | 2019 |
|
RU2723387C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY IN CHRONIC HEPATITIS C IN ADULTS AND CHILDREN | 2014 |
|
RU2589283C2 |
METHOD FOR PREDICTING ANTIVIRAL TREATMENT RESPONSE IN CHRONIC HEPATITIS C | 2013 |
|
RU2557534C2 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2012 |
|
RU2486526C1 |
DIAGNOSTIC TECHNIQUE FOR HEPATIC CIRRHOSIS (STAGE F4) IN THE OUTCOME OF CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2724595C1 |
METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC VIRAL HEPATITIS C | 2013 |
|
RU2546032C2 |
METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
METHOD FOR PREDICTION OF STABLE VIROLOGICAL RESPONSE TO ANTI-VIRAL THERAPY OF CHRONIC VIRAL HEPATITIS C ACCOMPANYING HIV INFECTION | 2013 |
|
RU2558793C2 |
Authors
Dates
2012-09-20—Published
2011-02-14—Filed